Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Fallon Esther Chipidza, M.D.

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Merkel Cell120203000.570 Why?
Diagnostic Techniques and Procedures120162140.480 Why?
Lymphoma, Non-Hodgkin1202113810.470 Why?
Mastectomy2202117930.470 Why?
Anger120164020.470 Why?
Hodgkin Disease1202114150.460 Why?
Lymphoma, Large B-Cell, Diffuse1202113780.400 Why?
Prostatic Neoplasms52023111240.310 Why?
Radiotherapy, Adjuvant3202317700.300 Why?
Zimbabwe320211290.300 Why?
Skin Neoplasms1202056860.190 Why?
Breast Neoplasms32021208220.180 Why?
Botswana1202110400.160 Why?
Delivery of Health Care1201653190.160 Why?
Prostate-Specific Antigen2202324940.140 Why?
Multiple Pulmonary Nodules120181530.140 Why?
Radiation Oncology120215550.130 Why?
Retrospective Studies82023774490.110 Why?
Kaplan-Meier Estimate2202065380.110 Why?
Data Collection1202133410.100 Why?
Aggression120167530.100 Why?
Neoplasm Staging32020110310.100 Why?
Patient Compliance1202126840.090 Why?
Tumor Suppressor Protein p531202029480.090 Why?
High-Throughput Nucleotide Sequencing1202135970.080 Why?
Proportional Hazards Models22020123540.080 Why?
Radiosurgery1201713290.080 Why?
Tumor Microenvironment1202035860.080 Why?
Carcinoma, Pancreatic Ductal1201816340.080 Why?
Mutation22021297860.070 Why?
Drug Prescriptions1201616370.070 Why?
Prognosis32022290630.070 Why?
Gene Expression Regulation, Neoplastic1202184280.060 Why?
Humans1520237443430.060 Why?
Prostate2202317740.060 Why?
Adjuvants, Pharmaceutic12023500.060 Why?
Lung Neoplasms22018131020.060 Why?
Physician-Patient Relations1201632290.050 Why?
Neoadjuvant Therapy2202327280.050 Why?
Pancreatic Neoplasms1201852560.050 Why?
Analgesics, Opioid1201636740.040 Why?
Health Services Misuse120212430.040 Why?
Carcinoma, Non-Small-Cell Lung1201752210.040 Why?
Cancer Care Facilities120214020.040 Why?
Salvage Therapy1202312750.040 Why?
Male820233501180.040 Why?
Survival Rate22021127880.030 Why?
SEER Program1202015080.030 Why?
Prostatectomy1202318900.030 Why?
Risk Assessment12016233380.030 Why?
Needs Assessment1202011470.030 Why?
Treatment Outcome12020631140.030 Why?
DNA Repair1202220460.030 Why?
Neoplasms12021216830.030 Why?
Female520213801940.030 Why?
Middle Aged520212133830.020 Why?
Risk1202096870.020 Why?
Aged420201632800.020 Why?
Palliative Care1202134930.020 Why?
Neoplasm Recurrence, Local1202392390.020 Why?
Clinical Trials as Topic1202079130.020 Why?
Health Services Accessibility1202151370.010 Why?
Age Factors12020183700.010 Why?
Incidence12020209470.010 Why?
Follow-Up Studies12021390500.010 Why?
Case-Control Studies12017217460.010 Why?
Cohort Studies12020405610.010 Why?
Tomography, X-Ray Computed12018201290.010 Why?
Adult220212140550.010 Why?
Risk Factors12021722900.010 Why?
United States12020698720.010 Why?
Chipidza's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (44)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.